This company has been marked as potentially delisted and may not be actively trading. Akili (AKLI) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AKLI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video GameJune 18, 2024 | businesswire.comAKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLIJune 14, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT, SGE on Behalf of ShareholdersJune 7, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, WIRE on Behalf of ShareholdersJune 5, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. – AKLIJune 5, 2024 | globenewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. - AKLIJune 4, 2024 | prnewswire.comAKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to ShareholdersJune 3, 2024 | businesswire.comAkili to be delisted after getting acquiredMay 29, 2024 | bizjournals.comShareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public ShareholdersMay 29, 2024 | prnewswire.comPureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29, 2024 | businesswire.comVirtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29, 2024 | businesswire.comAkili reports Q1 results; suspends outlookMay 15, 2024 | msn.comAKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | investorplace.comAkili Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | businesswire.comTherapeutic video game maker Akili lays off workers for third time in 16 monthsMay 3, 2024 | bizjournals.comWhy Is Akili (AKLI) Stock Up 68% Today?April 30, 2024 | investorplace.comAkili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsApril 30, 2024 | businesswire.comAkili (Nasdaq:AKLI) HeadlineTrading was temporarily halted for "AKLI" at 07:04 AM with a stated reason of "News pending."...April 30, 2024 | marketbeat.comDigital medicine maker Akili slashed executive pay in 2023March 11, 2024 | bizjournals.comAkili Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 3, 2024 | finance.yahoo.comAkili (AKLI) Gets a Buy from TD CowenMarch 1, 2024 | markets.businessinsider.comAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateFebruary 29, 2024 | businesswire.comPreview: Akili's EarningsFebruary 28, 2024 | benzinga.comAkili's ADHD digital therapy seeks Japan approvalFebruary 28, 2024 | investing.comCrude Oil Gains 1%; US New Home Sales Increase In JanuaryFebruary 27, 2024 | msn.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 27, 2024 | businesswire.comWhy Is Akili (AKLI) Stock Up 110% Today?February 26, 2024 | investorplace.comWhy Is Prescription Digital Medicine-Focused Akili Stock Trading Over 100% On Monday?February 26, 2024 | msn.comAkili's ADHD device submitted for Japanese approval, stock rallies 130%February 26, 2024 | seekingalpha.comAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | finance.yahoo.comAkili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | businesswire.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesFebruary 21, 2024 | finance.yahoo.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesFebruary 21, 2024 | businesswire.comAkili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?January 15, 2024 | finance.yahoo.comAkli Tadjer: French writer meets students in school race rowJanuary 8, 2024 | bbc.comBWhat to Know About EndeavorRX, the Video Game to Treat ADHDDecember 26, 2023 | cnet.comAkili, Inc. (AKLI) Upgraded to Buy: Here's What You Should KnowDecember 21, 2023 | finance.yahoo.comThe Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resignsDecember 21, 2023 | bizjournals.comAkili Inc Ordinary SharesDecember 19, 2023 | morningstar.comMEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17December 18, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and Akili (AKLI)November 15, 2023 | markets.businessinsider.comAkili Inc Ordinary Shares AKLINovember 14, 2023 | morningstar.comMAkili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | finance.yahoo.comAkili Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 10, 2023 | finanznachrichten.deEmployees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study FindsOctober 14, 2023 | tmcnet.comEmployees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study FindsOctober 12, 2023 | finance.yahoo.comAkili Announces Leadership TransitionOctober 6, 2023 | finance.yahoo.comAnalyst Affirms Buy Rating for Akili, Emphasizing Shift to OTC Strategy and Potential Strategic PartnershipsOctober 5, 2023 | markets.businessinsider.comBuy Rating on Akili’s Stock: Strategic Shift, Cash Management, and Anticipated FDA Clearances Bolster OptimismOctober 2, 2023 | markets.businessinsider.comAkili Releases EndeavorOTC(TM) on Android(TM) Devices, Expanding Treatment Access for Millions of Adults with ADHDSeptember 21, 2023 | stockhouse.com Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKLI Media Mentions By Week AKLI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKLI News Sentiment▼0.000.79▲Average Medical News Sentiment AKLI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKLI Articles This Week▼00▲AKLI Articles Average Week Get the Latest News and Ratings for AKLI and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Akili and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Lakeland Industries News Profound Medical News Pro-Dex News Avita Medical News Lucid Diagnostics News Jin Medical International News Hyperfine News Orchestra BioMed News InspireMD News EDAP TMS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKLI) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akili, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akili With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKLI Stock Alerts